GUIDE
Cosmetic Peptides
Explains cosmetic ingredient context and why cosmetic use is not drug approval.
What to ask your clinician
Which claims are label-based, which are investigational, and which safety warnings apply to your situation?
Evidence distinction
Human randomized data, observational reports, animal studies, and marketing claims are ranked separately.
Regulatory distinction
Approved medications, supplements, cosmetic ingredients, compounded products, and RUO compounds are not equivalent.
Plain-English guide
Explains cosmetic ingredient context and why cosmetic use is not drug approval.
Use this guide as a map, not a recommendation list. Start by separating approved product labels from research-only, supplement, cosmetic, and marketing claims. Then compare evidence grade, route, safety score, and source quality before reading individual peptide profiles.
For any peptide with an approved product context, the official label is the primary source for indications, warnings, contraindications, and adverse reactions. For investigational or research-use-only entries, treat the profile as a source-review starting point rather than proof of safety or effectiveness.
Ranked entries
Acetyl tetrapeptide-3
Topical hair and skin-care ingredient context
Argireline
Topical cosmetic expression-line ingredient context
Biotinoyl tripeptide-1
Topical hair-care ingredient context
Collagen peptides
Skin, joint, and nutrition supplement context
GHK-Cu
Cosmetic skin-care ingredient and wound/skin biology research
HCG
Hormone medication context; included because users search it near peptides
Hexapeptide-11
Topical skin-care ingredient context
Matrixyl
Topical cosmetic skin-care ingredient context
Palmitoyl oligopeptide
Topical skin-care ingredient context
Palmitoyl tetrapeptide-7
Topical skin-care ingredient context
Palmitoyl tripeptide-1
Topical skin-care ingredient context
Thymus peptides
Immune supplement and research-adjacent context
Tripeptide-29
Topical skin-care ingredient context